Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer

Aim: To observe the efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment for patients with human epidermal growth factor receptor 2 (HER-2) negative advanced gastric cancer. Methods: 80 eligible patients with HER-2 negative advanced gastric cancer admitted to Jin...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Guohu, Sun, Changchun, Cui, Lihua, Huang, Yufeng, Yu, Lijiang, Liu, Shenzha, Tao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350525/
https://www.ncbi.nlm.nih.gov/pubmed/37465317
http://dx.doi.org/10.3389/pore.2023.1611114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350525/
https://www.ncbi.nlm.nih.gov/pubmed/37465317
http://dx.doi.org/10.3389/pore.2023.1611114

Ejemplares similares